Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease

Noradrenergic and dopaminergic neurons are involved in cognitive functions, relate to behavioral and psychological symptoms in dementia and are affected in Alzheimer’s disease (AD). Amyloid plaques (A), neurofibrillary tangles (T) and neurodegeneration (N) hallmarks the AD neuropathology. Today, the...

Full description

Bibliographic Details
Main Authors: Blennow, K. (Author), Bollerslev, J. (Author), Eldholm, R.S (Author), Godang, K. (Author), Halaas, N.B (Author), Henjum, K. (Author), Knapskog, A.B (Author), Saltvedt, I. (Author), Watne, L.O (Author), Zetterberg, H. (Author)
Format: Article
Language:English
Published: Springer Nature 2022
Subjects:
Alzheimer disease
Alzheimer Disease
amyloid beta protein
Amyloid beta-Peptides
biological marker
Biomarkers
catecholamine
Catecholamines
cerebrospinal fluid
cognitive defect
Cognitive Dysfunction
complication
dopamine
Dopamine
epinephrine
Epinephrine
human
Humans
neurogranin
Neurogranin
noradrenalin
Norepinephrine
peptide fragment
Peptide Fragments
tau protein
tau Proteins
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items